0 followers
Many cancers and other diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly.​ We're progressing first-in-class antigen modulators through the clinic, developed to treat disease by controlling T cell activation. Our technology modulates antigen presenta... Read more
Peter Joyce
This company has no teams yet
QuellTX
4 followers
Nanoscope Therapeutics Inc.
1 follower
The Academy of Medical Sciences
1 follower
MaxWell Biosystems
1 follower
Oxford Nanopore Technologies
7 followers
VaxCare
1 follower
Vaxcyte
2 followers
Vera Therapeutics
2 followers
Merck
222 followers
Qkine
2 followers
Diligenta - a subsidiary of Tata Consultancy Services
3 followers
Explore companies